Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome

Journal of Human Virology

Volumn 1, Issue 1, 1997, Pages 19-29

  Kellam, Paul ^a   Boshoff, Chris ^a   Whitby, Denise ^a   Matthews, Stephen ^a   Weiss, Robin A ^a   Talbot, Simon J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Herpesvirus; Immunofluorescence; Kaposi's sarcoma; Latency; Nuclear antigen

Indexed keywords

EPITOPE; LATENT NUCLEAR ANTIGEN (LNA); MESSENGER RNA; NUCLEAR PROTEIN; PHOSPHOPROTEIN; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL NUCLEUS; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOLOGY; KAPOSI SARCOMA; METABOLISM; MOLECULAR GENETICS; OPEN READING FRAME; SEQUENCE HOMOLOGY; VIROLOGY; VIRUS GENOME; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GENOME, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNODOMINANT EPITOPES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; OPEN READING FRAMES; PHOSPHOPROTEINS; RNA, MESSENGER; SARCOMA, KAPOSI; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

EID: 0031261173     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Beral V. Epidemiology of Kaposi's sarcoma. In: Beral V, Jaffe HW, Weiss RA, eds. Cancer, HIV and AIDS 10. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1991:5-22.
2. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW. Cancer in Kampala, Uganda in 1989-91: changes in incidence in the era of AIDS. Int J Cancer 1993;54:23-36.
3. Chang, Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-1869.
4. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996;70:549-558.
5. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 1996;93:14862-14867.
6. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma [letter]. Lancet 1995;345:1043-1044.
7. Dupin N, Gorin I, Deleuze J, Agut H, Huraux JM, Escande JP. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease [letter]. N Engl J Med 1995;333: 798-799.
8. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995;1:705-706.
9. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-1280.
10. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-1191.
11. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
12. Boshoff C, Talbot S, Kennedy M, O'Leary J, Schulz T, Chang Y. HHV8 and skin cancers in immunosuppressed patients. Lancet 1996;348:138.
13. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. Lytic growth of Kaposi's sarcomaassociated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996;2:342-346.
14. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995;86:2708-2714.
15. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-861.
16. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-924.
17. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2:925-928.
18. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;348: 1133-1138.
19. Rickinson AB. Changing seroepidemiology of HHV-8. Lancet 1996;348:1110-1111.
20. Graham FL, Smiley J, Russel WC, Nairn R. Characteristics of a human cell line transformed by DNA from human Adenovirus type 5. J Gen Virol 1977;36:59-72.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
22. Henikoff S. Unidirectional digestion with exonuclease III in DNA sequence analysis. Methods Enzymol 1987;155: 156-165.
23. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987;7: 2745-2752.
24. Thome M, Schneider P, Hofmann K, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997;386:517-521.
25. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335:233-241.
26. Rogers RP, Strominger JL, Speck SH. Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency. Adv Cancer Res 1992;58:1-26.
27. Liebowitz D, Kieff E. Epstein-Barr Virus. In: Roizman B, Whitley RJ, Lopez C, eds. The human herpesviruses, vol. 1. New York: Raven Press, 1993:107-172.
28. Meinl E, Hohlfeld R, Wekerle H, Fleckenstein B. Immortalization of human T cells by herpesvirus saimiri. Immunol Today 1995;16:55-58.
29. Bertin J, Armstrong RC, Ottilie S, et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci U S A 1997;94:1172-1176.
30. Renz A, Fackelmayer FO. Purification and molecular cloning of the scaffold attachment factor B (SAF-B), a novel human nuclear protein that specifically binds to S/MAR-DNA. Nucleic Acids Res 1996;24:843-849.
31. Hanover JA. The nuclear pore: at the crossroads. FASEB J 1992;6:2288-2295.
32. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994;77:791-793.